Postoperative Outcomes Similar With Mobile App Follow-up for Ambulatory Breast Reconstruction

Patients using the mobile app attended 0.40 times fewer in-person visits for follow-up care following breast reconstruction.
Patients using the mobile app attended 0.40 times fewer in-person visits for follow-up care following breast reconstruction.

Mobile app follow-up care can be suitably targeted to low-risk postoperative ambulatory patients, according to researchers at the University of Toronto. The researchers found that patients who underwent ambulatory breast reconstruction and used a mobile app for follow-up care had fewer in-person visits during the first 30 days after the operation without affecting complication rates or patient-reported satisfaction.1

Reporting their findings in the journal JAMA Surgery, the investigators conducted a randomized clinical trial with 65 women (mean age, 47.7 years) who were divided into 2 groups: mobile app group (n = 32) and an in-person follow-up care group (n = 33). The app allowed patients to submit photos and answers to a quality of recovery questionnaire. Surgeons were able to follow patient reports on a web portal.

The researchers found that patients using the mobile app attended 0.40 times fewer in-person visits for follow-up care. They also sent more emails to their health care team during the first 30 days after surgery than did patients in the in-person follow-up group. The study also showed that the mobile app group was more likely to agree or strongly agree that their type of follow-up care was convenient. Complication rates and patient satisfaction scores were comparable between the groups.

The investigators in this study believe their findings are clinically relevant because the findings suggest a more convenient and cost-effective delivery of care for patients.

References

1. Armstrong KA, Coyte PC, Brown M, et al. Effect of home monitoring via mobile app on the number of in-person visits following ambulatory surgery a randomized clinical trial. JAMA Surg. 2017 Mar 22. doi: 10.1001/jamasurg.2017.0111 [Epub ahead of print]

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs